Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(3.82)
# 341
Out of 5,127 analysts
53
Total ratings
46%
Success rate
12.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $100 | $62.92 | +58.93% | 5 | Feb 10, 2026 | |
| QURE uniQure | Reiterates: Buy | $70 | $24.71 | +183.29% | 6 | Feb 10, 2026 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.39 | +2,464.10% | 2 | Feb 10, 2026 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $32.77 | +205.16% | 2 | Feb 4, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $570 → $510 | $322.98 | +57.90% | 3 | Jan 30, 2026 | |
| GOSS Gossamer Bio | Reiterates: Buy | $10 | $2.33 | +329.18% | 1 | Jan 22, 2026 | |
| DRUG Bright Minds Biosciences | Reiterates: Buy | $115 | $74.88 | +53.58% | 3 | Dec 30, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $15 | $7.51 | +99.73% | 2 | Dec 30, 2025 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $27.48 | +81.95% | 2 | Dec 22, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $40 | $1.88 | +2,027.66% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.55 | +545.16% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $27.48 | +118.34% | 3 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $37.93 | +45.00% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $0.84 | +1,087.37% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $3.70 | +575.68% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.33 | +128.31% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.63 | +513.50% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $50 | $16.65 | +200.30% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.65 | +158.06% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $26.95 | +196.85% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.85 | +289.61% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $4.48 | +1,574.11% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.18 | +596.38% | 2 | Sep 12, 2025 |
Arrowhead Pharmaceuticals
Feb 10, 2026
Reiterates: Buy
Price Target: $100
Current: $62.92
Upside: +58.93%
uniQure
Feb 10, 2026
Reiterates: Buy
Price Target: $70
Current: $24.71
Upside: +183.29%
Sangamo Therapeutics
Feb 10, 2026
Reiterates: Buy
Price Target: $10
Current: $0.39
Upside: +2,464.10%
Immunocore Holdings
Feb 4, 2026
Reiterates: Buy
Price Target: $100
Current: $32.77
Upside: +205.16%
Alnylam Pharmaceuticals
Jan 30, 2026
Maintains: Buy
Price Target: $570 → $510
Current: $322.98
Upside: +57.90%
Gossamer Bio
Jan 22, 2026
Reiterates: Buy
Price Target: $10
Current: $2.33
Upside: +329.18%
Bright Minds Biosciences
Dec 30, 2025
Reiterates: Buy
Price Target: $115
Current: $74.88
Upside: +53.58%
Vir Biotechnology
Dec 30, 2025
Reiterates: Buy
Price Target: $15
Current: $7.51
Upside: +99.73%
Assembly Biosciences
Dec 22, 2025
Reiterates: Buy
Price Target: $50
Current: $27.48
Upside: +81.95%
NRx Pharmaceuticals
Dec 16, 2025
Reiterates: Buy
Price Target: $40
Current: $1.88
Upside: +2,027.66%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.55
Upside: +545.16%
Dec 3, 2025
Reiterates: Buy
Price Target: $60
Current: $27.48
Upside: +118.34%
Nov 24, 2025
Reiterates: Buy
Price Target: $55
Current: $37.93
Upside: +45.00%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.84
Upside: +1,087.37%
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $3.70
Upside: +575.68%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $15.33
Upside: +128.31%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.63
Upside: +513.50%
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $16.65
Upside: +200.30%
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $4.65
Upside: +158.06%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $26.95
Upside: +196.85%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $3.85
Upside: +289.61%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $4.48
Upside: +1,574.11%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $7.18
Upside: +596.38%